Market Overview

Sequenom Announces European Patent for Novel Methods Of Detecting Fetal Aneuploidy

Sequenom (NASDAQ: SQNM) today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong. The patent claims novel methods for detecting fetal aneuploidy using sequencing and was the first patent filing made in the EPO directed to such novel methods. Sequenom holds exclusive rights to the patent, an important part of Sequenom's prenatal diagnostic patent portfolio, with coverage across all countries in the European Union, and also including Liechtenstein, Monaco, Norway and Switzerland.

See full press release

Posted-In: News Guidance Financing Contracts Legal Management Global

 

Related Articles (SQNM)

Around the Web, We're Loving...

Get Benzinga's Newsletters